Back
Lumos Pharma Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
LUMO
Lumos Pharma
Last Price:
4.33
Seasonality Move:
7.61%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Lumos Pharma Price Quote
$4.33
+0.01 (+0.7%)
(Updated: November 27, 2024 at 5:29 AM ET)
Lumos Pharma Key Stats
Sell
34
Lumos Pharma (LUMO)
is a Sell
Day range:
$4.30 - $4.38
52-week range:
$1.37 - $4.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.99
P/B ratio:
7.6%
Volume:
90.1K
Avg. volume:
121.8K
1-year change:
43.05%
Market cap:
$37.4M
Revenue:
$2.1M
EPS:
$-4.29
How Much Does Lumos Pharma Make?
-
How Much Are Lumos Pharma's Sales Annually?
LUMO Revenues are $2.1M -
How Much Profit Does Lumos Pharma's Make A Year?
LUMO net income is -$34M
Is Lumos Pharma Growing As A Company?
-
What Is Lumos Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 102.71% -
What Is Lumos Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Lumos Pharma Stock Price Performance
-
Did Lumos Pharma Stock Go Up Last Month?
Lumos Pharma share price went down by -1.82% last month -
Did LUMO's Share Price Rise Over The Last Year?
LUMO share price rose by 43.05% over the past 1 year
What Is Lumos Pharma 52-Week High & Low?
-
What Is Lumos Pharma’s 52-Week High Share Price?
Lumos Pharma has traded as high as $4.58 over the past 52 weeks -
What Is Lumos Pharma’s 52-Week Low Share Price?
Lumos Pharma has traded as low as $1.37 over the past 52 weeks
Lumos Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Lumos Pharma?
-
How Much Debt Does Lumos Pharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Lumos Pharma Have?
Cash and short term investments quarterly total is $13.5M -
What Is Lumos Pharma’s Book Value Per Share?
Book value per share is 0.57
Is Lumos Pharma Cash Flow Positive?
-
What Is LUMO Cash Flow From Operations?
Cash flow from operations (TTM) is -$31.7M -
What Is Lumos Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $2.5M -
What Is Lumos Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $7.2M
Lumos Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
LUMO return on invested capital is -182.95% -
What Is Lumos Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -112.43% -
What Is LUMO Return On Equity?
ROE is a measure of profitability and is -182.95%
Lumos Pharma Earnings Date & Stock Price
-
What Is Lumos Pharma's Stock Price Today?
A single share of LUMO can be purchased today for 4.32 -
What Is Lumos Pharma’s Stock Symbol?
Lumos Pharma trades on the nasdaq under the ticker symbol: LUMO -
When Is Lumos Pharma’s Next Earnings Date?
The next quarterly earnings date for Lumos Pharma is scheduled on March 7, 2025 -
When Is LUMO's next ex-dividend date?
Lumos Pharma's next ex-dividend date is November 27, 2024 -
How To Buy Lumos Pharma Stock?
You can buy Lumos Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Lumos Pharma Competitors
-
Who Are Lumos Pharma's Competitors?
Below is a list of companies who compete with Lumos Pharma or are related in some way:
Lumos Pharma Dividend Yield
-
What Is LUMO Dividend Yield?
Lumos Pharma’s dividend yield currently is 0% -
What Is Lumos Pharma’s Payout Ratio?
Lumos Pharma’s payout ratio is 0% -
When Did Lumos Pharma Last Pay A Dividend?
The latest dividend pay date is November 27, 2024 -
What Is Lumos Pharma’s Dividend Per Share?
Lumos Pharma pays a dividend of $0.00 per share
Lumos Pharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 10271.43% | 186.67% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 4.25 |
| Downside from Last Price: | -1.62% |